These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25698086)

  • 1. An epidemic model with a multistage vaccine.
    DeLegge A; Hunzinger K; Khatri R; Munir K
    Bull Math Biol; 2015 Mar; 77(3):499-513. PubMed ID: 25698086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal control of vaccination dynamics during an influenza epidemic.
    Jaberi-Douraki M; Moghadas SM
    Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse effects of the herd immunity or when childhood vaccination becomes deleterious for the epidemiology of infectious diseases in adults].
    Lang PO
    Geriatr Psychol Neuropsychiatr Vieil; 2011 Mar; 9(1):11-9. PubMed ID: 21586372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children.
    Gilca V; De Serres G; Hamelin ME; Boivin G; Ouakki M; Boulianne N; Sauvageau C; Dionne M; Gilca R; Skowronski D
    Vaccine; 2011 Dec; 30(1):35-41. PubMed ID: 22063386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual Vaccination as Nash Equilibrium in a SIR Model with Application to the 2009-2010 Influenza A (H1N1) Epidemic in France.
    Laguzet L; Turinici G
    Bull Math Biol; 2015 Oct; 77(10):1955-84. PubMed ID: 26443437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal individual strategies for influenza vaccines with imperfect efficacy and durability of protection.
    Salvarani F; Turinici G
    Math Biosci Eng; 2018 Jun; 15(3):629-652. PubMed ID: 30380323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory.
    Loew-Baselli A; Pavlova BG; Fritsch S; Poellabauer EM; Draxler W; Kistner O; Behre U; Angermayr R; Neugebauer J; Kirsten K; Förster-Waldl E; Koellges R; Ehrlich HJ; Barrett PN
    Vaccine; 2012 Sep; 30(41):5956-66. PubMed ID: 22846396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
    Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza.
    Kung HC; Huang KC; Kao TM; Lee YC; Chang FY; Wang NC; Liu YC; Lee WS; Liu HJ; Chen CI; Chen CH; Huang LM; Hsieh SM
    Vaccine; 2010 Oct; 28(45):7337-43. PubMed ID: 20817013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The coexistence or replacement of two subtypes of influenza.
    Asaduzzaman SM; Ma J; van den Driessche P
    Math Biosci; 2015 Dec; 270(Pt A):1-9. PubMed ID: 26453807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
    Prosper O; Saucedo O; Thompson D; Torres-Garcia G; Wang X; Castillo-Chavez C
    Math Biosci Eng; 2011 Jan; 8(1):141-70. PubMed ID: 21361405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the Netherlands.
    van't Klooster TM; Kemmeren JM; de Melker HE; Vermeer-de Bondt PE; van der Maas NA
    Hum Vaccin; 2011 Oct; 7(10):1048-54. PubMed ID: 21957494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Universal influenza vaccination and live attenuated influenza vaccination of children.
    Glezen WP
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S104-9. PubMed ID: 18820568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age.
    Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G
    Pediatr Infect Dis J; 2014 Dec; 33(12):e320-9. PubMed ID: 24978857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.
    Fiore AE; Shay DK; Haber P; Iskander JK; Uyeki TM; Mootrey G; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2007 Jul; 56(RR-6):1-54. PubMed ID: 17625497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of an AS03-adjuvanted A(H1N1)pmd09 vaccine administered simultaneously or sequentially with a seasonal trivalent vaccine in adults 61 years or older: data from two multicentre randomised trials.
    Peeters M; Regner S; Vaman T; Devaster JM; Rombo L
    Vaccine; 2012 Oct; 30(45):6483-91. PubMed ID: 22885014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.
    Knuf M; Leroux-Roels G; Rümke HC; Abarca K; Rivera L; Lattanzi M; Pedotti P; Arora A; Kieninger-Baum D; Della Cioppa G
    Vaccine; 2015 Jan; 33(1):174-81. PubMed ID: 25444803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.